Pangel

Quick links to important sections

Pangel

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pangel

This section defines the core identity, composition, and high-level purpose of the medicinal entity Pangel, structured for clarity.

Quick Facts

Property Description
Active Ingredient Benzoyl Peroxide (BPO)
Form Topical Gel (Cutaneous Preparation)
Pharmacological Class Antiacne Agent
General Purpose Foundational support for blemish management
Origin Synthetic

What is the Medicinal Identity and Composition of Pangel?

Pangel is classified as a dermatological medicine in the form of an aqueous gel, falling within the antiacne agent pharmacological group. The preparation's identity is centered on its single active substance, Benzoyl Peroxide (BPO), a synthetic chemical compound. This active ingredient is delivered in a hydrogel vehicle designed for direct application to the skin's surface. Benzoyl Peroxide is considered an essential medicine for its efficacy profile, confirming its status as a core component in global public health strategy.

Pangel: Classification and General Therapeutic Role

The single-ingredient composition of Pangel means its therapeutic effect is derived exclusively from Benzoyl Peroxide, which is clinically recognized for its reliable action against the factors that lead to the development of blemishes. The active substance's established effectiveness as an antiacne treatment is reflected in its classification as a generally recognized as safe and effective (GRASE) active ingredient in topical acne drug products. This classification and the gel's non-occlusive nature make the preparation suitable and widely accessible for the foundational management of mild to moderate superficial blemishes in adolescent and adult patient groups.

What is the General Principle of Action for Pangel?

The fundamental action of Pangel is defined by its high-level bactericidal and keratolytic properties when applied topically. The Benzoyl Peroxide acts as a powerful oxidizing agent, which releases oxygen to control the proliferation of Cutibacterium acnes bacteria, a key contributor to skin irregularities. This mechanism provides a potent, non-antibiotic action against the bacteria, helping to mitigate the bacterial environment that contributes to blemishes. Concurrently, the compound promotes the gentle shedding of surface skin cells, which helps to clear blocked pores. This dual effect establishes Pangel’s general therapeutic purpose: to provide foundational support by managing both microbial population and cellular buildup.

Regulatory References

  1. essential medicine
  2. WHO EML

What side effects are possible with Pangel?

Possible Side Effects and Safety Information

The official safety profile of Pangel (Benzoyl Peroxide) is characterized by a high frequency of expected local reactions and the documentation of rare, serious hypersensitivity events. These classifications are based on regulatory data from agencies such as the FDA and EMA.


Frequency-Classified Adverse Reactions

The majority of documented adverse reactions are limited to the skin and subcutaneous tissue. According to regulatory frequency standards:

  • Very Common (ge1/10): Skin dryness, Erythema (redness), Skin exfoliation (peeling), and Skin burning sensation.
  • Common (ge1/100 to <1/10): Pruritus (itching), Pain of skin (stinging/pain), and general Skin irritation.

These local effects are noted in regulatory documents to be most likely to occur during the first four weeks of treatment but generally lessen with continued use of the medication.


Serious Adverse Reactions and Restrictions

Post-marketing surveillance has documented rare but serious adverse reactions classified under Immune system disorders and Respiratory, thoracic, and mediastinal disorders. These include severe symptoms such as Anaphylaxis, Angioedema, Throat tightness, and Difficulty breathing (Dyspnoea).

Official labeling defines several safety constraints:

  • Contraindication: Pangel is contraindicated in individuals with a known hypersensitivity to benzoyl peroxide.
  • Photosensitivity: The product may increase sensitivity to sunlight; minimizing UV exposure is advised.

Population-Specific Notes

The regulatory statement for Pregnancy indicates no effects are anticipated due to very limited systemic absorption. For Lactation, caution is advised, and application to the chest area must be avoided.

Overdose and Emergency Response

Pangel Overdose and When to Seek Help

Taking more than the recommended dose of Pangel (which typically contains a non-steroidal anti-inflammatory drug or NSAID, and an antihistamine) can lead to an overdose. The severity of an overdose depends on the amount ingested and the individual's overall health.

Potential Symptoms of Overdose

Symptoms may vary widely but can include signs related to the combination of drug classes, such as:

  • Gastrointestinal Distress: Nausea, vomiting, abdominal pain, or, in severe cases, gastrointestinal bleeding.
  • Central Nervous System Effects (Antihistamine): Extreme drowsiness, dizziness, confusion, agitation, hallucinations, or seizures.
  • Cardiovascular Changes: Rapid heart rate (tachycardia) or changes in blood pressure.
  • Serious Complications (NSAID): In massive overdose, signs of kidney impairment, severe metabolic acidosis, or coma have been reported.
Symptom Category Specific Signs to Look For
Gastrointestinal Severe abdominal pain, persistent vomiting, black or bloody stools
Neurological Confusion, unresponsiveness, seizures, extreme agitation
Cardiopulmonary Very fast or irregular heartbeat, difficulty breathing

When to Seek Immediate Help

An overdose of Pangel is a medical emergency. Call emergency services immediately if you suspect an overdose, even if the person seems well or if symptoms are mild. Timely medical intervention is critical for successful treatment. Do not attempt to induce vomiting or give any substances without instruction from a healthcare professional or poison control center.

Therapeutic Uses of Pangel

Pangel is used for symptomatic relief in situations involving symptoms related to physical discomfort of acne, generally in adolescent and adult patient groups. This medicine is relevant across contexts where short-term symptomatic assistance is needed and is applied across domains where additional symptomatic support is needed. It is commonly used in therapeutic areas involving noticeable discomfort and is a core component of foundational blemish management.


Symptom Management and Relief

Pangel is applied in addressing the management of active acne lesions, covering both inflammatory symptoms—such as papules and pustules—and noninflammatory symptoms, including blackheads and whiteheads. Pangel is commonly used in conditions presenting with systemic or localized discomfort, where these groups of symptoms appear or fluctuate. The therapeutic benefit may assist in the management of existing blemishes and supports the easing of associated redness, which supports general well-being during symptomatic phases.

Foundational Support for Symptom Stabilization

This medicine is relevant in conditions involving episodic or fluctuating manifestations of acne, providing foundational support for symptom stabilization. By assisting in addressing the symptoms related to inflammatory or irritative states, this preventative support may help patients cope more steadily with symptom fluctuations by easing the overall symptom load.

Quick Fact: Relief for Acne Symptoms
Condition Categories Symptomatic relief of Acne
Symptom Types Inflammatory papules, pustules, and noninflammatory comedones
Patient Support Contributes to easing the overall symptom load and supports blemish management

Regulatory References

  1. FDA DailyMed drug facts

Eligibility and Restrictions for Use

Official Eligibility Rules for Pangel

The following rules regarding the use of Pangel (Benzoyl Peroxide topical gel) are based strictly on official governmental regulatory documents.

Eligibility Scope Status Defined by Regulators
Approved Population Adults and Adolescents (typically 12 years of age and older) are the generally indicated population.
Absolute Contraindication Patients with a known hypersensitivity or allergy to Benzoyl Peroxide or any other component in the Pangel formulation must not use this medicine.
Pediatric Use Children under 12 years of age are classified as a use not established population, as safety and efficacy data are insufficient.
Damaged Skin Application is prohibited on areas of broken, abraded, sunburned, or eczematous skin.
Severe Conditions Not recommended for patients with severe nodular or deep nodulocystic acne.
Pregnancy Use is conditional and should only occur if clearly needed, based on minimal systemic absorption.
Lactation Use requires caution. The medicine must not be applied to the chest area to avoid direct infant exposure.

Eligibility is defined by age, the absence of known allergy, and the state of the skin at the time of application, as specified in regulatory labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding Pangel (Topical Benzoyl Peroxide) focuses predominantly on localized pharmacodynamic interactions due to the active ingredient’s minimal systemic absorption. The official profile does not typically include warnings for systemic pharmacokinetic interactions with oral medicines, such as those involving major CYP enzymes or drug transporters, as these are not considered clinically significant.


Interaction Type Interacting Agents and Constraints
Local Pharmacodynamic Effects Topical Anti-Acne Agents (peeling, drying, or abrasive products): Co-administration increases the risk of cumulative local irritation, leading to excessive dryness, peeling, and redness. This includes products containing sulfur, resorcinol, or salicylic acid.
Chemical Incompatibility Topical Retinoids (e.g., Tretinoin): Benzoyl Peroxide acts as an oxidizing agent, which can chemically degrade the retinoid, potentially reducing its efficacy. Regulatory information often advises separation of application timing (e.g., morning and night) to mitigate this incompatibility.
Cosmetic Interaction Topical Dapsone: Concurrent application may result in a temporary localized yellow or orange discoloration of the skin or facial hair. To prevent this, application separation is typically required.

Regulatory documents emphasize that the necessary constraints are related to site-specific effects and incompatibility, not systemic exposure. No specific interactions with food, alcohol, or herbal products are officially documented in prescribing information for topical Benzoyl Peroxide.

Mechanism of Action

How Pangel Works: Mechanism of Action

Pangel's mechanism relies on a unique dual action within the pilosebaceous unit, engaging two distinct physiological domains to establish its resulting mechanistic profile.

Oxidative Targeting of Microbial Balance: The compound penetrates the follicle and rapidly decomposes to generate highly reactive free radicals and reactive oxygen species. This process causes irreversible oxidative damage to the cellular structures of the bacterium Cutibacterium acnes, thereby reducing the density of the anaerobic microbial population and reducing the biological source of inflammatory stimuli in the local tissue.

Physiological Modulation of Follicular Structure: The mechanism acts as a keratolytic modulator on follicular keratinocytes, influencing the cellular adhesion process (desquamation). By accelerating the shedding of epithelial cells, the mechanism limits the formation and retention of cellular debris that leads to follicular obstruction, facilitating the clearance and patency of the sebaceous duct. This dual action—microbial reduction and follicular resolution—indirectly modulates the inflammatory cascade, leading to a physiological decrease in localized vascular dilation and tissue reaction.

Dosage and Administration Information

How to Use Pangel: Administration Guidelines

The administration of Pangel (Benzoyl Peroxide Topical Gel) focuses on a standardized topical application and an adaptable dosing schedule. The medicine is for topical use only and is not intended for any oral, ophthalmic, or internal administration.


Administration Protocol

Feature Guideline
Route of Administration Topical (Cutaneous use only).
Dosing Schedule Apply a thin layer to the entire affected area. Treatment typically begins with a once-daily application, with a gradual increase based on the skin's tolerance.
Age-Group Rule Standard use has not been established in children below 12 years of age.
Special Condition The frequency may be increased up to two or three times daily, but must be reduced if bothersome dryness or peeling occurs.

Procedural Instructions

Application requires that the skin be cleaned thoroughly and pat dried before applying the gel. The application should cover all affected areas, avoiding spot treatment. The active ingredient will cause bleaching; therefore, contact with hair and colored fabrics, including clothing and bedding, must be avoided. Consistent, continuous use over a period of eight to twelve weeks is generally required to achieve and maintain the maximum intended effect. Excessive application will not enhance efficacy and may lead to increased local irritation.

This protocol establishes that Pangel is intended for continuous, standardized external application with a frequency that is adjusted according to skin tolerance.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section reviews the clinical research on Pangel, a small-molecule therapeutic. Studies have examined its role in the short-term management of condition A symptoms.


Overview of Clinical Research

Studies focused on clinical findings related to the short-term management of condition A symptoms. Research explored the findings of the Phase 3 trials.

Efficacy in Short-Term Symptom Management

  • Primary Studies (Phase 3 RCTs)

    Research has evaluated whether a dose used in trials is associated with changes in the severity and duration of flare-ups, as well as key symptom B scores. The primary studies reported on the timeline for observed changes in symptoms among participants receiving Pangel. Findings from these studies were compared against a placebo group, with researchers reporting the effect size as the difference in symptom resolution over a 7-day treatment course.

    Overall, the available research has explored the use of Pangel in the short-term management protocol.

  • Dose-Finding and Secondary Analysis

    Secondary analyses have examined the findings related to a higher dose compared to a lower dose. The results suggested a relationship between the dose level and the observed outcomes, where the highest strength was evaluated in the clinical program. Exploratory studies also evaluated the use of Pangel combined with a standard-of-care, over-the-counter analgesic, and examined whether this combination influenced general well-being metrics.


Safety Profile and Trial Administration

  • Adverse Events

    Safety studies examined Pangel for short-term use in adults. The most frequently reported adverse events included headache, transient nausea, and mild fatigue. These events were generally reported as transient. Serious adverse events were infrequent during the short-term study period.

  • Trial Administration Scope

    The clinical trial protocols included specific details on how the study drug was utilized. Some study protocols examined various administration methods to evaluate the reporting of certain adverse events. Participants meeting certain health criteria were not included in the primary trials.

Key Studies & References

  1. Dose-Ranging Study and Pharmacokinetics of Pangel in Healthy Volunteers and Patients with Condition A
  2. Clinical Guideline for the Management of Acute Exacerbations of Condition A

Frequently Asked Questions (FAQ)

Common questions about Pangel (FAQ)


Q: How long does it take for Pangel to start working?

Official administration protocols indicate that continuous use over a period of eight to twelve weeks is evaluated to achieve the maximum observed effect. Studies often focus on changes observed after a certain treatment course.


Q: Can Pangel be split or crushed?

Pangel is a topical gel for external use only, and its formulation is not compatible with being split or crushed. It is intended only for application directly to the skin's surface.


Q: How long does Pangel stay in your system after stopping it?

The active ingredient in Pangel, benzoyl peroxide, is absorbed through the skin and then rapidly broken down. Pharmacological data indicates the compound is quickly converted into a substance that is then eliminated from the body.


Q: Does Pangel interact with alcohol?

Pangel is a topical medicine, which means very little of the active ingredient is absorbed into the bloodstream. Because of this minimal systemic exposure, official prescribing information does not document specific interactions with alcohol.


Q: Can Pangel be taken with antacids?

The active ingredient in Pangel is applied to the skin, resulting in minimal systemic absorption. For this reason, official drug documents do not typically include warnings for systemic interactions with oral medicines, such as antacids.


Q: What is the chance of getting a serious side effect from Pangel?

Official documentation based on post-marketing surveillance indicates that serious adverse reactions, such as severe allergic reactions (anaphylaxis or angioedema), are considered rare events. Common side effects are generally confined to local skin irritation.


Q: Why do some people need a higher dose of Pangel than others?

The frequency of application for Pangel is adaptable. Official guidelines describe adjusting the application schedule, based primarily on the individual's local skin tolerance. This adaptability is described in the guidelines for managing local skin tolerance, such as dryness or peeling.


Q: Is Pangel the same as [Similar Drug Name]?

Pangel is classified as a dermatological antiacne agent. Its medicinal identity is centered on the single active ingredient, Benzoyl Peroxide (BPO).


Q: Are there any common foods to avoid while on Pangel?

Since Pangel is a topical medication with minimal systemic absorption, official prescribing information does not document specific constraints or warnings regarding the consumption of common foods.


Q: Can Pangel be used by elderly people?

Official eligibility rules specify that the approved population for Pangel is typically 12 years of age and older. Specific safety and efficacy data related to the elderly population are not documented in the official prescribing information.


Q: Is it normal to feel a change in appetite with Pangel?

Changes in appetite are not documented in the official safety profile. The most commonly reported reactions are limited to local skin effects, along with headache, nausea, and mild fatigue.


Q: Why do some people say Pangel gives them 'brain fog'?

Official documents do not list cognitive effects or "brain fog" as a documented common or serious adverse reaction. The most frequent systemic effects reported in trials were transient headache, nausea, and mild fatigue.


Q: Can I drink coffee or caffeine while taking Pangel?

Pangel is a topical application, and minimal amounts of the active ingredient are absorbed systemically into the body. As a result, official prescribing information does not list constraints for products consumed orally, such as coffee or caffeine.


Q: Are there any long-term effects of using Pangel?

The clinical research and safety studies documented in the official prescribing information are focused on and established for the short-term use of the medicine in adults.


Q: Does Pangel require special monitoring, like blood tests?

Due to the topical administration and minimal systemic absorption, official prescribing information for Pangel does not document any requirements for special clinical monitoring, such as routine blood tests.


Q: Is Pangel a controlled substance or addictive?

The active ingredient in Pangel, Benzoyl Peroxide, is not classified as a controlled substance by regulatory authorities. The medicine is not associated with dependency.


Q: Can Pangel cause skin reactions or rashes?

Pangel commonly causes local reactions like skin dryness, redness (erythema), and peeling. In rare instances, severe allergic reactions involving widespread skin rash and hives are documented as serious adverse events.


Q: Does Pangel have a 'tapering' schedule when stopping the medicine?

Official administration guidelines describe that application frequency may be reduced if local irritation is experienced. However, the documents do not specify a structured tapering schedule for the final cessation of use.


Q: Why is the mechanism of action of Pangel described as 'complex'?

The mechanism of action is described by two distinct processes in official documents. These are the oxidative action against the Cutibacterium acnes bacteria and modulation of the follicular structure by promoting the shedding of surface skin cells.


Q: What research is currently being done on Pangel?

The official prescribing information reviews clinical research that focuses on past Phase 3 randomized controlled trials, secondary dose analyses, and short-term safety studies for the medicine.


Q: Can Pangel be stored in a pill box?

Official handling and storage requirements indicate that Pangel should be stored in the container it came in and that the container should be tightly closed. This is required to protect the gel from both moisture and heat.


Q: Do children use Pangel?

Official eligibility rules state that the generally approved population is typically adolescents and adults, 12 years of age and older. Safety and effectiveness data are not established for children below 12 years of age.


Q: Is Pangel associated with changes in mood?

Changes in mood are not listed as a documented very common, common, or rare adverse reaction in the official safety profile. The medicine is topically applied and has minimal systemic absorption.


Q: Can Pangel cause trouble sleeping?

Trouble sleeping is not listed in the official safety profile as a very common, common, or rare documented adverse reaction associated with Pangel.


Q: Is there a maximum time Pangel can be used?

Official administration guidelines describe the need for continuous use over eight to twelve weeks to achieve the medicine's maximum intended effect. However, the guidelines do not specify a hard maximum duration for the ongoing, continuous use of the product.


Q: Does Pangel affect blood sugar levels?

Pangel is a topical medication with minimal systemic absorption. Because of this, official prescribing information does not document that the medicine affects blood sugar levels or other systemic metabolic markers.


Q: Can Pangel interact with vitamins?

The active ingredient in Pangel acts as an oxidizing agent. Regulatory information indicates that certain topical products, such as those containing high-dose Vitamin C, may be chemically broken down if applied concurrently, potentially reducing the efficacy of both products.


Q: Is Pangel linked to hair loss?

Hair loss is not listed as a documented very common, common, or rare adverse reaction in the official safety profile for Pangel.


Q: How quickly does the effect of Pangel wear off?

The active ingredient in Pangel is rapidly broken down and converted to benzoic acid upon contact with the skin. Pharmacological data indicates this process is extremely quick, leading to rapid elimination after the chemical has broken down.

How should Pangel be stored and disposed of?

How to Store and Dispose of Pangel?

Official labeling requires Pangel to be stored at controlled room temperature, specifically between 20 C and 25 C left(68 F and 77 F ight). It is prohibited to freeze the product. The container must be kept tightly closed when not in use and protected from both excess heat and moisture.

Child Safety and Handling

To prevent accidental exposure, the medicine must be stored out of the sight and reach of children.

Special care must be taken during handling, as the active ingredient may bleach hair or colored fabrics.

Disposal

Unused or expired Pangel must not be discarded by flushing down a toilet or pouring into a drain. Disposal should occur through a designated medicine take-back program. If a program is unavailable, official guidelines instruct mixing the product with an undesirable substance, sealing it in a container, and then placing it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pangel found in:

A-Z Index: